Eric Lefkofsky, The Man Behind Groupon is Focusing on Big Data to Propel His New Venture to Success

Through the exploitation of big data, a Chicago-based startup is keen on championing personalized cancer therapies. Currently, personalized health care in the fight against cancer is a preserve for the wealthy individuals because it involves sequencing of a person’s genome. The startup aims at leveraging the power of technology, specifically machine learning and data collected from patients who’ve battled cancer to create the new age treatments.

The startup is called Tempus. It was created by two entrepreneurs, Mr Eric Lefkofsky and Brad Keywell.

The company is a first in the collection of big data for cancer patients. It was built on the premise of availing big data for decision making in the fight against cancer. Tempus has based its main offices in Chicago.

Recently, the firm made a major pronouncement. It has entered into a partnership with the University of Chicago to provide genome sequencing and analysis of close to 1,000 breast cancer patients to the University. The breast cancer experts at the institution’s Department of Oncology will then use the data to come up with tailored treatment plans for patients. This approach to cancer treatment is hinged on the fact that different factors such as genetic makeup affect the response of a patient to treatment.

Big data is the basis upon which modern day professionals make decisions. In the long term, the data collected by Tempus will help guide doctors on how they can achieve effective treatment and better patient outcomes. Click here to know more.

Currently, oncologists make treatment decisions based on the limited knowledge they have learned. With big data, doctors will have more detailed and genetic-specific information that could help them make better decisions when administering therapies.

The irony of cancer treatment is that in as much as there are over 1.7 million new cases of cancer that are reported in the US yearly, the public healthcare has data for only 20,000 patients. To achieve the concept of personalized healthcare in the fight against cancer succeeds more resources have to be devoted towards collection and analysis of this data.

The founder of Tempus, Eric Lefkofsky is also the brainchild of acclaimed brands such Groupon, Lightbank, Drivin and Mediabank.

Facebook: https://www.facebook.com/eplefkofsky/

Leave a Reply

Your email address will not be published. Required fields are marked *